President and Chief Executive Officer
In 2017, Douglas Ingram earned a total compensation of $56.9M as President and Chief Executive Officer at Sarepta Therapeutics.
|Ranking||20 out of 13,165|
Douglas Ingram's 2017 compensation ranked 20th out of 13,165 executive pay records tracked by us this year.
Douglas Ingram earned more than 99.8% of all executives tracked by us in 2018.
|Ranking||1 out of 1,094|
In the industry of pharmaceutical preparations, Douglas Ingram's 2017 pay ranked 1st out of 1,094 executive pay records tracked by us.
Douglas Ingram earned more than 99.9% of executives in this industry.
|Non-Equity Incentive Plan||$420,875|
Ingram received $44.5M in option awards, which accounts for 78.23% of total compensation.
Ingram also received $420.9K in non-equity incentive plan, $337.5K in salary, $11.6M in stock awards and $16.1K in other compensation.